ZURA Zura Bio
- 4.620
- -0.260-5.33%
Zura Bio News
EFFECT: Others
8-K: Current report
424B7: Prospectus
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
4: Statement of changes in beneficial ownership of securities-Director Ploos van Amstel Arnout
10-Q/A: Quarterly report (Amendment)
8-K: Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
10-Q: Quarterly report
D: Filing D
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.1%),Peter Kolchinsky(5.1%), etc.
SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
4: Statement of changes in beneficial ownership of securities-Officer Howell Michael
4: Statement of changes in beneficial ownership of securities-Officer Nistala Kiran
4: Statement of changes in beneficial ownership of securities-Director Munshi Amit
4: Statement of changes in beneficial ownership of securities-Director Sidhu Someit
8-K: Current report
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.34%),Deep Track Biotechnology Master Fund, Ltd.(9.34%), etc.
Zura Bio | 8-K: Current report
Zura Bio | 8-K: Current report
Analysis
Price Target
No Data
